Interstitial Lung Disease Healthcare
Interstitial Lung Disease Treatment Market May 2017 Report Id : REP-GB-3261 Status : Ongoing Category : Healthcare, Pharmaceuticals & Medical Devices ©2015 Future Market Insights, All Rights Reserved About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Customized Research Syndicated Research Investment Research Social Media Research Customized Research Syndicated Research Investment Research Social Media Research Sector Coverage Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Subscription Information For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com ©2015 Future Market Insights, All Rights Reserved 2 Research Methodology (1/2) Systematic Research Approach 1 Market profiling 2 Formulating discussion guide 3 Developing list of respondents 4 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. PMR formulates a detailed discussion guide to conduct expert and industry interviews PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts Data collection PMR conducts interviews with industry experts, industry players, distributors and retailers Data validation Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data 5 6 Data analysis Insights 7 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry PMR delivers industry insights and information in the required format (PDF) Data Collection Research & Intelligence Data Filter & Analysis Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Actionable Insights A Primary Research B SOLUTION Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments Primary Research # Linkedin Zoominfo Salesforce Avention Business Solution Desk Research C Key industry experts Channel study Developments Market dynamics Products Conclusions Company Analysis Secondary Research # Company websites Company annual reports White papers Financial reports Paid Publications# Factiva GBI Genios Meltwater # includes sources of databases ©2015 Future Market Insights, All Rights Reserved 3 Interstitial Lung Disease Treatment Market Interstitial lung disease (ILD) is a general category that includes many different lung conditions. All interstitial lung diseases affect the interstitium, a part of the lung's anatomic structure. The interstitium is a lace-like network of tissues that extends throughout both lungs. The interstitium provides support to the lung’s microscopic air sacs (alveoli). Tiny blood vessels travel through the interstitium, allowing gas exchange between blood and the air in the lungs. The disease affects the lungs in three ways. First, the lung tissue is damaged. Second, the interstitium becomes inflamed. Finally, fibrosis (scarring) begins in the alveoli (air sacs) and interstitium, and the lung becomes stiff, making it difficult to breathe. Interstitial lung disease treatment includes a diverse collection of illnesses with a variety of causes, treatments, and prognoses. Individuals who suffer from interstitial lung disease often have difficulty breathing and moving from place to place due to a consistent feeling of shortness of breath. Disorders classified under interstitial lung disease are often characterized by scarring of the lung's delicate tissues and a dry, pestering cough. Interstitial lung disease is caused by environmental factors, removing these triggers can slow the progression of the disease and damage to the lungs. Interstitial Lung Disease Treatment Market: Dynamics Registries of the epidemiology of different interstitial lung disease have been compiled in several countries. However, they remain scarce due to the difficulties that arise in obtaining a specific diagnosis as many of these conditions are rare. More than 250,000 people have been diagnosed with interstitial lung disease in the United States, and nearly five million people have been diagnosed worldwide. It is estimated that more than 41,000 ©2015 Future Market Insights, All Rights Reserved 4 Interstitial Lung Disease Treatment Market patients die each year from interstitial lung disease worldwide. The outlook for patients with interstitial lung disease varies depending on the underlying cause of the disease. There is no absolute cure for interstitial lung disease available as yet. A large portion of the treatment is directed to provide temporary relieve to the patients. Failure to provide a complete cure and limited treatment options are considered as major setbacks of the market. Limited drug options with low efficiency are further hindering the growth of the global interstitial lung disease treatment market. UCSF has an active research program conducting both clinical and basic research in the pathogenesis of lung fibrosis. Through the generosity of patients, who collaborate with world-class physician scientists, they have developed a better understanding of the fundamental, cellular and molecular mechanisms of interstitial lung disease. The clinical research involves both observational studies and clinical trials that use the knowledge gained in basic research to study the benefits of novel treatments in patients with lung fibrosis.\ Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3261 Antibiotics may be given if a bacterial infection is responsible for the condition. Management of the underlying disease process is also essential in a person with interstitial lung disease related to these conditions. If the disease is thought to involve hypersensitivity, then the best therapy is avoidance of this offending substance. Depending on the severity of the symptoms, respiratory support, including supplemental oxygen and even ventilator support, may be required. Respiratory therapists may be part of a treatment team with the goal of improving day to day function. ©2015 Future Market Insights, All Rights Reserved 5 Interstitial Lung Disease Treatment Market Smoking cessation is an essential part of the treatment for anyone with interstitial lung disease. Interstitial Lung Disease Treatment Market: Region-wise Outlook Geographically, the market is segmented into North America, Eastern Europe, Western Europe, AsiaPacific excluding Japan, Japan Latin America, and the Middle East and Africa in which North America holds a major share of the market for interstitial lung disease treatment Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3261 Interstitial Lung Disease Treatment Market: Key Players Some of the hospitals and clinics providing treatment for interstitial lung disease treatment are Cleveland, Barnes-Jewish Hospital, Brigham and Women's Hospital, Massachusetts General Hospital, Johns Hopkins Hospital, Stanford Health Care, and UCSF Medical Center. Over the past decade, the definition of interstitial lung disease and thus enrollment criteria for this disease have become more specific. However, study design remains a challenge as there is continued debate on what constitutes a clinically meaningful endpoint. ©2015 Future Market Insights, All Rights Reserved 6 To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Harish Tiwari (General Manager & Global Head Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Thank You Future Market Insights Global & Consulting Private Limited (FMI) ©2015 Future Market Insights, All Rights Reserved 7
© Copyright 2024